In a report by Punch on September 4th, 2023, it was explained that changes occur in the ovaries due to the rupture of the follicle and turnover of the ovarian wall.
Ovarian cancer is more common in menopausal women, particularly those who experience late menopause in their 50s. This is because the number of times a woman ovulates during her reproductive life increases the likelihood of developing ovarian cancer.
To address concerns related to ovulation, menstrual disorders, or fertility issues, it is advised that women seek medical attention from maternal health specialists.
A study conducted in Nigeria and published in the Journal of Epidemiology and Global Health revealed that ovarian cancer is the second most common and deadliest gynecological malignancy in the country.
However, a 2020 study by Uppsala University in Sweden found that the use of oral contraceptives can protect against ovarian and endometrial cancer.
The study, which involved more than 250,000 women, demonstrated that the protective effect of oral contraceptives persists for several decades even after discontinuation.
The researchers compared the incidence of breast, ovarian, and endometrial cancers between women who had used oral contraceptive pills and those who had not. They discovered that women who had used oral contraceptives had a significantly lower risk of developing both ovarian and endometrial cancer.
Even after fifteen years of discontinuing oral contraceptives, the risk remained approximately 50% lower. Interestingly, a reduced risk was still observed up to 30-35 years after discontinuation.
Furthermore, the study found only a small increased risk of breast cancer among oral contraceptive users, and this increased risk disappeared within a few years after discontinuation.
No comments:
Post a Comment